MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Comparison of Disease Progression in Patients with Brain-first versus Body-first Parkinson’s Disease

DW. Ryu, SW. Yoo, KS. Lee, SG. Ha, JS. Kim (Seoul, Republic of Korea)

Meeting: 2022 International Congress

Abstract Number: 1492

Keywords: Denervation, Parkinson’s

Category: Parkinson's Disease: Non-Motor Symptoms

Objective: This study aimed to compare the clinical progression between brain-first and body-first PD groups using cardiac sympathetic denervation (CSD).

Background: Brain-first and body-first Parkinson’s disease (PD) are disease classifications based on the origin site of α-synuclein pathology.

Method: This study included 29 brain-first and 103 body-first PD patients. Using 123I-meta-iodobenzylguanidine (123I-MIBG) scintigraphy, heart to mediastium (H/M) ratio and wash-out rate were measured; and CSD was determined using the initial delayed H/M ratio. Clinical chracteristics, dopamine transporter activity, and non-motor manifestations were compared between the groups. Motor symptoms and cognitive function between initial presentation and 3.4 (± 1.5) years from initial tests were compared between the groups.

Results: Early and delayed H/M ratio decreased more steeply in brain-first PD than in body-first PD during the follow-up period. REM sleep behavioral disorder, excessive daytime sleepiness, constipation, orthostatic hypotension, and memory and frontal executive domain dysfunctions were more frequent in body-first PD than in brain-first PD. However, smell identification test scores were not different between the groups. Unified Parkinson’s Disease Rating Scale part III score was higher at initial presentation and increased more steeply in body-first PD patients than in brain-first PD patients during the follow-up period. However, no significant differences were found in cognitive scores during follow-up.

Conclusion: Our results demonstrate that brain-first and body-first PD based on CSD onset can be effective classifications. Patients in these classifications can experience different clinical presentations and progression in motor symptoms; body-first PD had more severe motor symptom at initial presentation and more steep motor deterioration than brain-first PD.

To cite this abstract in AMA style:

DW. Ryu, SW. Yoo, KS. Lee, SG. Ha, JS. Kim. Comparison of Disease Progression in Patients with Brain-first versus Body-first Parkinson’s Disease [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/comparison-of-disease-progression-in-patients-with-brain-first-versus-body-first-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/comparison-of-disease-progression-in-patients-with-brain-first-versus-body-first-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley